A broad range of services include:

• Weekly and as-needed meetings
• Review of Phase I-IV Studies, single and multiple investigator
• Review of Medical Device Studies
• Expedited review of studies as identified in the Federal Register
• Revisions and maintenance of approved Informed Consent documents
• Informed Consent composition
• Document translation

IntegReview's fee schedule is subject to change without notice.

You will be invoiced an additional charge of $500 for late study submissions and an additional charge of $200 for late continuing review submissions.

Download our current Fee Schedule (revised 09/18/2008)